Skip to main content

Surface Oncology, Inc.

SURFDelisted Sep 8, 2023
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001718108

Surface Oncology, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Sep 8, 2023; 62 institutions reported holding it in 13F filings for Q2 2023, worth $16.9M in total; ARK Invest was the only superinvestor holding it.

13F holders, Q2 2022

Institutional positions in Surface Oncology, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
85
−17 vs. Q1 2022
Shares held
28.9M
−2.95M (−9.3%) vs. Q1 2022
Total value
$48.6M
−$45.1M (−48.1%) vs. Q1 2022
New holders
15
27 more added
Sold out
32
23 more reduced

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting SURF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 85 institutions
Q1 2021: 91 institutionsQ2 2021: 97 institutionsQ3 2021: 92 institutionsQ4 2021: 107 institutionsQ1 2022: 104 institutionsQ2 2022: 85 institutionsQ3 2022: 80 institutionsQ4 2022: 80 institutionsQ1 2023: 72 institutionsQ2 2023: 62 institutionsQ3 2023: 2 institutionsQ4 2023: 1 institutionQ1 2024: 1 institutionQ2 2024: 1 institutionQ3 2024: 1 institutionQ4 2024: 1 institutionQ1 2025: 1 institutionQ2 2025: 1 institutionQ3 2025: 1 institutionQ4 2025: 1 institutionQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2022: $48.6M
Q1 2021: $147.5MQ2 2021: $168.5MQ3 2021: $182.2MQ4 2021: $118.0MQ1 2022: $93.8MQ2 2022: $48.6MQ3 2022: $32.8MQ4 2022: $23.4MQ1 2023: $18.8MQ2 2023: $16.9MQ3 2023: $21.3KQ4 2023: $21.0KQ1 2024: $21.0KQ2 2024: $21.0KQ3 2024: $21.0KQ4 2024: $21.0KQ1 2025: $21.0KQ2 2025: $21.0KQ3 2025: $21.0KQ4 2025: $21.0KQ1 2026: $0Q2 2026: $0
Institutions holding SURF and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20251$21.0K
Q3 20251$21.0K
Q2 20251$21.0K
Q1 20251$21.0K
Q4 20241$21.0K
Q3 20241$21.0K
Q2 20241$21.0K
Q1 20241$21.0K
Q4 20231$21.0K
Q3 20232$21.3K
Q2 202362$16.9M
Q1 202372$18.8M
Q4 202280$23.4M
Q3 202280$32.8M
Q2 202285$48.6M
Q1 2022104$93.8M
Q4 2021107$118.0M
Q3 202192$182.2M
Q2 202197$168.5M
Q1 202191$147.5M

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Surface Oncology, Inc.; share changes are against Q1 2022.

Institutions holding SURF in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Corton Capital Inc.0$00.00%−17,586−100.0%Sold out
California State Teachers Retirement System0$00.00%−15,019−100.0%Sold out
Alliancebernstein L.P.0$00.00%−12,600−100.0%Sold out
Delphia (USA) Inc.0$00.00%−12,075−100.0%Sold out
ProShare Advisors LLC0$00.00%−11,399−100.0%Sold out
Invesco Ltd.0$00.00%−10,736−100.0%Sold out
Manufacturers Life Insurance Company, The0$00.00%−10,416−100.0%Sold out
SG Americas Securities, LLC0$00.00%−10,043−100.0%Sold out
LPL Financial LLC0$00.00%−10,100−100.0%Sold out
Legal & General Group Plc0$00.00%−5,409−100.0%Sold out
Amalgamated Bank0$00.00%−4,256−100.0%Sold out
Ameritas Investment Partners, Inc.0$00.00%−2,609−100.0%Sold out
Simplex Trading, LLC0$00.00%−2,477−100.0%Sold out
Point72 Hong Kong Ltd0$00.00%−2,508−100.0%Sold out
Cutler Group LP0$00.00%−1,200−100.0%Sold out
Toronto Dominion Bank0$00.00%−4−100.0%Sold out
Bedel Financial Consulting, Inc.0$00.00%−100−100.0%Sold out
Parametric Portfolio Associates LLC––––Not filed
Amalgamated Financial Corp.––––Not filed